Molecules 2012, 17, 4962-4971; doi:10.

3390/molecules17054962
OPEN ACCESS

molecules
ISSN 1420-3049
www.mdpi.com/journal/molecules
Article

Synthesis and Antimicrobial Evaluation of

Some Pyrazole Derivatives
Essam Mohamed Sharshira 1,* and Nagwa Mohamed Mahrous Hamada 2,*
1
Department of Chemistry, Faculty of Science, Alexandria University, Alexandria 21321, Egypt
2
Department of Chemistry, Faculty of Education, Alexandria University, Alexandria 21526, Egypt

* Authors to whom correspondence should be addressed; E-Mails: dressamsharshira@yahoo.com

(E.M.S.); nagwahamada2002@yahoo.com (N.M.M.H.).

Received: 20 February 2012; in revised form: 23 March 2012 / Accepted: 18 April 2012 /
Published: 30 April 2012

Abstract: Reaction of a series of (E)-3-phenyl-4-(p-substituted phenyl)-3-buten-2-ones

with p-sulfamylphenyl hydrazine in glacial acetic acid gave the corresponding hydrazones,
subsequent treatment of which with 30% HCl afforded pyrazole-1-sulphonamides. On
the other hand, refluxing of chalcones with either thiosemicarbazide or isonicotinic
acid hydrazide in ethanol containing a few drops of acetic acid gave pyrazoline-1-
thiocarboxamides and isonicotinoyl pyrazolines, respectively. The structures of the
synthesized compounds were determined on the basis of their elemental analyses and
spectroscopic data. The antimicrobial activity of the newly isolated heterocyclic
compounds was evaluated against Gram-positive, Gram-negative bacteria and fungi. Most
of the compounds showed a moderate degree of potent antimicrobial activity.

Keywords: isonicotinic acid hydrazide; sulphonamide; pyrazoles; antimicrobial activities 

1. Introduction

Pyrazoles and their variously substituted derivatives are important biological agents and a
significant amount of research activity has been directed towards this class. In particular, they are used
as antitumor [1], antibacterial and antifungal, antiviral, antiparasitic, anti-tubercular and insecticidal
agents [2–10]. Some of these compounds have also anti-inflammatory, anti-diabetic, anesthetic and
analgesic properties [11–14]. Moreover, chalcones have played a crucial part in the development of
theory of heterocyclic compounds, and also they used extensively in organic synthesis [15–19].
Molecules 2012, 17 4963

A classical synthesis of these compounds involves the base-catalyzed aldol condensation reaction of
ketones and aldehydes to give α,β-unsaturated ketones (chalcones), which undergo a subsequent
cyclization reaction with hydrazines affording pyrazoles [11,20–22]. In recent years, a significant
portion of research in heterocyclic chemistry has been devoted to pyrazoles containing different aryl
groups, as evident from the literature [23–30].

2. Results and Discussion

A convenient route for the synthesis of α,β-unsaturated ketones 1a–e is achieved by base catalyzed
condensation of benzyl methyl ketone with the appropriate p-substituted benzaldehyde in the presence
of piperidine [31] (Scheme 1).

Scheme 1. Synthesis of compounds 1a–e, 2a–e, 3a–e, 4a–e, 5a–e.

The (E)-Configuration for 1a–e comes from 1H-NMR measurements where the vinyl proton of the
(E)-isomer appears at relatively higher field than the (Z)-one [32]. The hydrazone derivatives 2a–e
were obtained in good yields by heating 1a–e with p-sulphamylphenyl hydrazine in ethanol containing
few drops of glacial acetic acid. The IR of 2a–e showed the characteristic bands for C=N at
1,626–1,633, and primary and secondary amine bands at 3,379–3,391 and 3,289–3,310 cm−1,
respectively. The 1H-NMR spectra showed the presence of a singlet equivalent to one proton in the
range δ = 8.21–8.73 ppm characteristic for a hydrazone NH proton, while the primary amine NH2
protons appeared at δ = 9.23–9.40 ppm, a multiplet at δ = 7.31–7.82 ppm characteristic for the
Molecules 2012, 17 4964

aromatic protons, a singlet at δ = 6.89–6.97 ppm for N=C–C=CH and a singlet equivalent to three
protons at δ = 2.19–2.37 ppm characteristic for N=C-CH3 protons. Treatment of 2a–e with 30% HCl
produced the pyrazole derivatives 3a–e in good yields.
The IR of 3a–e showed the characteristic bands for C=N at 1,632–1,656, C=C at 1,500–1,520
whereas NH2 band appeared at 3,378–3,393 cm−1. The 1H-NMR spectra for 3a–e revealed the
following signals: A singlet equivalent to two exchangeable protons at δ = 9.33–10.37 ppm
characteristic for NH2 protons, a multiplet at δ = 7.13–8.29 ppm characteristic for the aromatic protons.
The methyl protons at C3 of the pyrazole ring appeared as a singlet at δ 2.22–2.28 ppm. In the case of
3b, another singlet appeared at δ = 3.34 ppm characteristic for OCH3 group at the p-position to phenyl
group. Finally, condensation of 1a–e with either thiosemicarbazide or isonicotinic acid hydrazide in
ethanol containing few drops of acetic acid gave pyrazolines 4a–e or 5a–e, respectively. The
pyrazoline structures were fully confirmed by spectral and elemental analyses methods (Tables 1 and 2).
The IR spectra of 4a–e lacked the carbonyl band but showed a thiocarbonyl band at 1,232–1,248 and
primary and secondary amine absorption bands at 3,387–3,394 and 3,282–3,316 cm−1 respectively. On
the other hand the IR of 5a–e showed an amide carbonyl band at 1,628–1,634 cm−1 and a primary
amine absorption band only. The 1H-NMR of either 4a–e or 5a–e revealed the presence of
an exchangeable hydrogen of one proton intensity for a NH proton at δ = 8.26–8.48 ppm or
8.31–8.51 ppm, respectively. In the case of 4a–e, another exchangeable hydrogens of two protons
intensity was also appeared at δ = 10.71–10.93 ppm characteristic for thiocarboxamide protons
(S=C–NH2). The pyrazole-C5-H for 4a–e and 5a–e appeared as a singlet at δ = 5.39–5.46 ppm and
5.37–5.47 ppm, respectively.

Table 1. Physical and analytical data of compounds 2a–e, 3a–e, 4a–e, and 5a–e.
Yield M.P. Molecular Calculated % Found %
Compound R
(%) (°C) Formula C H N C H N
2a H 67 147 C22H21N3SO2 67.52 5.37 10.74 67.50 5.40 10.70
2b OCH3 90 160 C23H23N3SO3 65.56 5.46 9.98 65.60 5.44 9.95
2c Cl 87 103 C22H20N3SO2Cl 61.97 4.69 9.86 61.94 4.66 9.90
2d Br 93 110 C22H20N3SO2Br 56.17 4.26 8.94 56.20 4.30 8.97
2e NO2 79 135 C22H20N4SO4 60.55 4.59 12.84 60.50 4.63 12.80
3a H 69 187 C22H19N3SO2 67.87 4.88 10.80 67.84 4.92 10.84
3b OCH3 91 193 C23H21N3SO3 65.87 5.01 10.02 65.90 5.05 10.06
3c Cl 76 172 C22H18N3SO2Cl 62.26 4.25 9.91 62.30 4.21 9.94
3d Br 78 177 C22H18N3SO2Br 56.41 3.85 8.97 56.45 3.90 8.95
3e NO2 69 197 C22H18N4SO4 60.83 4.15 12.90 60.80 4.15 12.94
4a H 81 149 C17H17N3S 69.15 5.76 14.24 69.10 5.76 14.20
4b OCH3 83 156 C18H19N3SO 66.46 5.85 12.92 66.50 5.85 12.95
4c Cl 87 172 C17H16N3SCl 61.82 4.85 12.73 61.86 4.88 12.69
4d Br 79 146 C17H16N3SBr 54.55 4.28 11.23 54.50 4.29 11.20
4e NO2 93 166 C17H16N4SO2 60.00 4.71 16.47 59.99 4.66 16.43
5a H 81 159 C22H19N3O 77.42 5.57 12.32 77.45 5.59 12.36
5b OCH3 69 166 C23H21N3O2 74.39 5.66 11.32 74.35 5.69 11.30
5c Cl 89 142 C22H18N3OCl 70.21 4.79 11.17 70.25 4.74 11.24
5d Br 86 168 C22H18N3OBr 62.86 4.29 10.00 62.82 4.25 10.05
5e NO2 97 171 C22H18N4O3 68.39 4.66 14.51 68.44 4.60 14.55
Molecules 2012, 17 4965

Table 2. IR and 1H-NMR spectral data of compounds 2a–e, 3a–e, 4a–e, and 5a–e.
IR cm−1 (KBr) 1
H-NMR (δ / ppm) a
Compound Vinyl NH and/or N=C-C=CH pyrazoline- CH3 and/or
C=N  C=O C=S  Ar-H’S (m)  NH and/or NH2 
HC=CH NH2  (s) C5-H (s) Ar- OCH3 (s)
2a 1603 1632 - - 3391, 3291 7.33–7.82 6.91 - 2.33 8.21 and 9.23
2b 1609 1629 - - 3389, 3309 7.31–7.81 6.93 - 2.22 and 3.26 8.46 and 9.29
2c 1612 1626 - - 3382, 3289 7.36–7.61 6.97 - 2.22 8.54 and 9.31
2d 1604 1633 - - 3383, 3302 7.41–7.71 6.89 - 2.19 8.61 and 9.39
2e 1619 1627 - - 3379,3310 7.26–7.76 6.95 - 2.37 8.73 and 9.40
3a 1515 1632 - - 3386 7.24–8.29 - - 2.25 9.33
3b 1510 1641 - - 3384 7.35–7.94 - - 2.28 and 3.34 9.76
3c 1500 1644 - - 3378 7.29–7.86 - - 2.22 9.92
3d 1515 1654 - - 3391 7.13–7.64 - - 2.25 9.71
3e 1520 1656 - - 3393 7.29–8.10 - - 2.28 10.37
4a 1527 - - 1246 3394, 3287 7.26–7.82 - 5.39 2.25 10.73 and 8.26
4b 1522 - - 1245 3390, 3293 7.27–7.77 - 5.42 2.32 and 3.39 10.77 and 8.37
4c 1531 - - 1248 3390, 3282 7.29–8.01 - 5.44 2.27 10.79 and 8.42
4d 1527 - - 1247 3393, 3311 7.23–7.61 - 5.46 2.29 10.93 and 8.43
4e 1526 - - 1232 3387, 3316 7.27–7.99 - 5.39 2.32 10.71 and 8.48
5a 1517 - 1630 - 3291 6.81–7.09 and 7.32–7.48 - 5.40 2.32 8.31
5b 1530 - 1628 - 3293 6.79–7.12 and 7.29–7.49 - 5.37 2.25 and 3.31 8.36
5c 1522 - 1631 - 3287 6.83–7.08 and 7.27–7.51 - 5.46 2.27 8.45
5d 1519 - 1633 - 3289 6.82–7.11 and 7.27–7.52 - 5.47 2.22 8.47
5e 1524 - 1634 - 3311 6.84–7.10 and 7.26–7.71 - 5.42 2.39 8.51
a
Solution in DMSO-d6.
Molecules 2012, 17 4966

2.1. Antimicrobial Activity 

All of our compounds, i.e., hydrazones 2a–e, pyrazoles 3a–e, pyrazolines 4a–e and 5a–e were
tested for antimicrobial activity against four test organisms: Staphylococcus aureus ATCC6538P,
Escherichia coli ATCC873, Pseudomonas aeruginosa ATCC9027 and Candida albicans ATCC2091
using rifampicin (5 g/disc) and ampicillin (10 g/disc) as standard drugs (Table 3).

Table 3. Antimicrobial activities of all the synthesized compounds.

Zone of inhibition (mm) Minimum inhibition concentration (MIC) g/mL
Compound
S. aureus C. albicans S. aureus C. albicans
2a - 20 - 250
2b - 15 - -
2c 17 20 100 50
2d 14 20 120 500
2e 12 15 - -
3a 19 22 63 31
3b 18 25 125 31
3c 22 26 50 50
3d 18 20 63 125
3e 17 17 - -
4a - 15 - -
4b - 15 - -
4c 21 20 100 50
4d 15 18 63 63
4e - 15 - -
5a - 15 - -
5b - 15 - -
5c 21 24 50 50
5d - 15 - -
5e 17 17 - -
Rifampicin 32 - - -
Ampicillin 30 - - -
DMSO - 14 - -
(-) Indicates no activity.

The agar well-diffusion method [33] was used for studying the potential activities of these
compounds. All compounds only showed potent activity against Staphylococcus aureus and
Candida albicans in the following ranking: 3a–e > 5a–e > 4a–e ≥ 2a–e. Minimum inhibitory
concentration (MIC) values for the individual compounds that showed inhibition zones > 10 were
determined by means of the agar well-diffusion method in DMSO. The results of antimicrobial
activities of our synthesized compounds against S. aureus and C. albicans are shown in Table 3 as
zone of inhibition (in mm) and minimum inhibitory concentration, MIC (mg/mL). The trend of activity
was observed as follows: X > H > OMe > NO2 where X = Cl, Br. Minimum bactericidal
concentrations (MBC) were determined for all chloro derivatives such as 1c, 2c, 3c, 4c and 5c which
exhibit good activities. These results are listed in Table 4.
Molecules 2012, 17 4967

Table 4. Determination of minimum bactericidal concentration (MBC) µg/mL of chloro-derivatives.

Concentrations µg/mL 1000 500 250 125 63 31 1000 500 250 125 63 31
Microorganism Growth S. aureus C. albicans
2c - - - + + + - - - - + +
3c - - - + + + - - - + + +
4c - - - + + + - - + + + +
5c - - + + + + - - - - + +

3. Experimental

3.1. General

Melting points were taken in open capillary tubes using an Electrothermal apparatus 9100
(Rochford, UK) and are uncorrected. Microanalyses were performed at Faculty of Science, Cairo
University, Cairo, Egypt, using an Elementary Vario el III C, H, N, S analyzer (Hanau, Germany). IR
spectra were recorded using potassium bromide disks on a Perkin Elmer Spectrum RXI/FT-IR System
(Faculty of Pharmacy, Alexandria University, Alexandria, Egypt). 1H-NMR spectra were determined
on a Varian EM-390 MHz spectrophotometer, using TMS as internal standard. 

3.2. General Procedure for Preparation of 3-Phenyl-4-(p-substituted phenyl)-3-buten-1-ones 1a–e

Compounds 1a–d were obtained in a good yield according to a published method [31]. The physical
properties and all the spectral data were as reported in the literature

3.3. General Procedure for Preparation of 3-Phenyl-4-(p-substituted phenyl)-3-buten-1-

(p-sulphamyl-phenyl)hydrazones 2a–e

A solution of the chalcone 1a–e (10 mmol) in ethanol (30 mL) was refluxed with the appropriate
amount of p-sulphamylphenylhydrazine (10 mmol) in glacial acetic acid (2 mL) for six hours, then the
reaction mixture was poured into crushed ice and kept overnight at room temperature. The separated
crude solid was filtered off, washed successively with water, dried and recrystallized from ethanol
(95%) to give 2a–e as needles. Physical and analytical data for the prepared compounds are shown in
Table 1. IR and 1H-NMR data are listed in Table 2.

3.4. General Procedure for Preparation of 3-Methyl-4-phenyl-5-(p-substituted phenyl)-1-

(p-sulphamyl-phenyl)pyrazoles 3a–e

A mixture of the appropriate hydrazones 2a–e (10 mmol) and 30% HCl (15 mL) was heated under
reflux for three hours and left to cool. After the reaction mixture reached room temperature, it was
poured into crushed ice and the oily product deposited was decanted from water and extracted with
ether. The ether layer was washed two times by water, dried over anhydrous sodium sulphate and
evaporated. The precipitate obtained was recrystallized from ethanol (95%) to afford the corresponding
pyrazoles 3a–e as needles. Physical and analytical data for 3a–e are as shown in Table 1. IR and
1
H-NMR data are shown in Table 2.
Molecules 2012, 17 4968

3.5. General Procedure for Preparation of 4,5-Dihydro-3-methyl-4-phenyl-5-(p-substituted phenyl)-

pyrazole-1-thiocarboxamides 4a–e

A mixture of the appropriate chalcone 1a–e (10 mmol) in ethanol (30 mL) was refluxed with the
appropriate amount of thiosemicarbazide (12 mmol) in glacial acetic acid (2 mL) for 17 hours, then the
reaction mixture was poured into crushed ice and was kept overnight at room temperature. The
separated crude solid was filtered off, washed successively with water, dried and recrystallized
from ethanol/chloroform to give 4a–e as needles. The results and characterization data are listed in
Tables 1 and 2.

3.6. General Procedure for Preparation of 4,5-Dihydro-3-methyl-4-phenyl-5-(p-substituted phenyl)-1-

isonicotinoylpyrazoles 5a–e

A mixture of the appropriate chalcone 1a–e (10 mmol) in ethanol (30 mL) was refluxed with
the appropriate amount of isonicotinic acid hydrazide (10 mmol) in glacial acetic acid (2 mL) for
five hours. The reaction mixture was treated as mentioned for the preparation of 4a–e to give
the corresponding pyrazole 5a–e. Physical and spectroscopic data of 5a–e are listed in Table 1 and
Table 2, respectively.

3.7. Determination of Antimicrobial Activity

All compounds were tested against four different microorganisms: Staphylococcus aurous,
Escherichia coli, Pseudomonas aeruginosa and Candida albicans. The agar well-diffusion method was
applied for the determination of inhibition zone and minimum inhibitory concentration (MIC). Briefly,
broth culture (0.75 mL) containing ca. 106 colon-forming units (CFU) per mL of the test strain was
added to nutrient agar medium (75 mL) at 45 °C, mixed well, and then poured into a 15 cm sterile
metallic Petri plate. The medium was allowed to solidify and 8 mm wells were dug with a sterile
metallic borer, then a DMSO solution of the test sample (1 mL) at 1 mg/mL was added to the
respective wells. DMSO served as negative control, and the standard antimicrobial drugs rifampicin
(5 g/disc) and ampicillin (10 g/disc) were used as positive controls. Triplicate plates for each
microorganism strain were prepared and were incubated aerobically at 37 °C for 24 h. The activity was
determined by measuring the diameter of zone showing complete inhibition (mm), thereby, the zones
were precisely measured with the aid of a Venier caliper (precision 0.1 mm). The growth inhibition
was calculated with reference to the positive control. For the individual compounds that showed
inhibition zones >10 mm, MIC values were determined by means of the agar well-diffusion method
for concentrations of 1.0, 0.50, 0.25, 0.125, 0.063 and 0.031 mg/mL in DMSO. The tests were
performed in triplicate, and the results were averaged. Minimum bactericidal concentrations (MBC)
were determined for all chloro derivatives which exhibit good activities (1c, 2c, 4c and 5c) for
concentrations of 1.0, 0.50, 0.25, 0.125, 0.063 and 0.031 mg/mL in DMSO. The results are listed in
Tables 3 and 4.
Molecules 2012, 17 4969

4. Conclusions

This work demonstrates a rapid, efficient method for synthesis of some pyrazole derivatives.
Compounds having pharmacophores such as chloro- and bromo-substituents with lipophilic properties
showed the greatest antimicrobial activity.

Acknowledgements

The authors wish to thank the management of microbiology lab, Faculty of Pharmacy, Alexandria
University, for their support to carry out the antimicrobial activity.

References and Notes

1. Taylor, E.C.; Patel, H.; Kumar, H. Synthesis of pyrazolo 3,4-dpyrimidine analogues of the potent
agent N-4-2-2-amino-43H-oxo-7H-pyrrolo2,3-dpyrimidin-5-yl ethylbenzoyl-L-glutamic acid
(LY231514). Tetrahedron 1992, 48, 8089–8100.
2. Abdel-Rahman, A.A.-H.; Abdel-Megied, A.E.-S.; Hawata, M.A.M.; Kasem, E.R.; Shabaan, M.T.
Synthesis and antimicrobial of some chalcones and their derived pyrazoles, pyrazolines,
isoxzolines and 5,6-dihydropyrimidine-2-(1H)-thiones. Monatsh. Chem. 2007, 138, 889–897.
3. Sharshira, E.M.; Hamada, N.M. Synthesis and in vitro antimicrobial activity of some pyrazolyl-1-
carboxamide derivatives. Molecules 2011, 16, 7736–7745.
4. Rashad, A.E.; Shamroukh, A.H.; Hegab, M.I.; Awad, H.M. Synthesis of some biologically active
pyrazoles and C-nucleosides. Acta Chim. Slov. 2005, 52, 429–434.
5. Rashad, A.E.; Hegab, M.I.; Abdel-Megeid, R.E.; Micky, J.A.; Abdel-Megeid, F.M.E. Synthesis
and antiviral evaluation of some new pyrazole and fused pyrazolopyrimidine derivatives.
Bioorg. Med. Chem. 2008, 16, 7102–7106.
6. Bhat, B.A.; Dhar, K.L.; Saxena, A.K.; Shanmugavel, M. Synthesis and biological evaluation of
chalcones and their derived pyrazoles as potential cytotoxic agent. Bioorg. Med. Chem. 2005, 15,
3177–3180.
7. Michael, L.E.; David, M.S.; Prasad, S.S. Chalcones: A new class of antimitotic agents. J. Med. Chem.
1990, 33, 1948–1954.
8. Kalirajan, R.; Sivakumar, S.U.; Jubie, S.; Gowramma, B.; Suresh, B. Synthesis and biological
evaluation of some heterocyclic derivatives of chalcones. Int. J. ChemTech Res. 2009, 1, 27–34.
9. Holla, B.S.; Akberali, P.M.; Sivanada, M.K. Studies on arylfuran derivatives: Part X. Synthesis
and antibacterial properties of arylfuryl-Δ2-pyrazolines. Farmaco 2000, 55, 256–263.
10. Maggio, B.; Daidone, G.; Raffa, D.; Plescia, S.; Mantione, L.; Cutuli, V.M.C.; Mangano, N.G.;
Caruso, A. Synthesis and pharmacological study of ethyl 1-methyl-5-(substituted-3,4-dihydro-4-
oxoquinazolin-3-yl)-1H-pyrazole-4-acetates. Eur. J. Med. Chem. 2001, 36, 737–742.
11. Vibhute, Y.B.; Basser, M.A. Synthesis and activities of a new series of chalcones as antibacterial
agents. Ind. J. Chem. 2003, 42B, 202–205.
12. Clinton, R.O.; Manson, A.J.; Stonner, F.W.; Beyler, A.L.; Potts, G.O.; Arnold, A. Steroidal [3,2-c]
pyrazoles. J. Am. Chem. Soc. 1959, 81, 1513–1514.
Molecules 2012, 17 4970

13. Kalirajan, R.; Palanivelu, M.; Rajamanickam, V.; Vinothapooshan, G.; Andarajagopal, K. 
Synthesis and biological evaluation of some heterocyclic derivatives chalcones. Int. J. Chem. Sci.
2007, 5, 73–80.
14. Urmila, G.; Vineeta, S.; Vineeta, K.; Sanjana, C. Synthesis and antifungal activity of new fluorine
containing 4-(substituted phenylazo) pyrazoles and isoxazoles. Indian J. Heterocycl. Chem. 2005,
14, 265–266.
15. Klimova, E.I.; Marcos, M.; Klimova, T.B.; Cecilio, A.T.; Ruben, A.T.; Lena, R.R. The structure
of bicyclic ferrocenylmethylene substituted 2-pyrazolines and their reactions with azodicarboxylic
acid N-phenylimide. J. Organomet. Chem. 1999, 585, 106–114.
16. Padmavathi, V.; Sumathi, R.P.; Chandrasekhar, B.N.; Bhaskar, D. 1,3-Dipolar cycloaddition of
dipolar reagents to bifunctional olefins in the presence of chloramine-T (CAT). J. Chem. Res. (S)
1999, 10, 610–611.
17. Faidallah, M.H.; Sharshira, E.M.; Basaif, A.S.; A-Ba-Oum, K.A. Synthesis and spectral
characterization of novel 1,3,4-oxadiazole and 1,2,4-triazole derivatives: Synthesis for potential
pharmacological activities. Phosphor. Sulfur Silicon Relat. Elem. 2002, 177, 67–79.
18. Vibhute, Y.B.; Basser, M.A. Synthesis and activities of a new series of chalcones as anti bacterial
agents. Ind. J. Chem. 2003, 42B, 202–205.
19. Hamada, N.M.; Sharshira, E.M. Synthesis and antimicrobial evaluation of some heterocyclic
chalcone derivatives. Molecules 2011, 16, 2304–2312.
20. Azarifar, D.; Shaabanzadeh, M. Synthesis and characterization of new 3,5-dinaphthyl substituted
2-pyrazolines and study of their antimicrobial activity. Molecules 2002, 7, 885–895.
21. Padmaia, A.; Payani, T.; Reddy, G.D.; Padmavathi, V. Synthesis, antimicrobial and antioxidant
activities of substituted pyrazoles, isoxazoles, pyrimidine and thioxopyrimidine derivatives.
Eur. J. Med. Chem. 2009, 44, 4557–4566.
22. Yale, H.L.; Lose, K.; Martins, J.; Holing, M.; Perry, F.M.; Bernstein, J. Chemotherapy of
experimental tuberculosis. VIII. The synthesis of acid hydrazides, their derivatives and related
compounds. J. Am. Chem. Soc. 1953, 75, 1933–1942.
23. Abdelhamid, A.O.; Zohidi, H.F.; Sallam, M.M.M.; Ahmed, N.A. Reactions with hydrazonoyl
halides. 31. Synthesis of some new pyrrolidino[3,4-c]pyrazolines, pyrazoles, and pyrazolo[3,4-
d]pyridazines. Molecules 2000, 5, 967–973.
24. Rurack, K.; Bricks, J.L.; Schultz, B.; Maus, M.; Reck, G.; Resch-Genger, U.J. Substituted1,5
diphenyl-3-benzothiazol-2-yl-Δ2-pyrazolines: Synthesis, X-ray structure, photophysics and cation
complexation properties. J. Phys. Chem. A 2000, 104, 6171–6188.
25. Guerra, F.M.; Mish, M.R.; Carreira, E.M. Versatile, diastereoselective additions of silyl ketene
acetals, allyl tributylstannane and Me3SiCN to N-acyl pyrazolines: Asymmetric synthesis of
densely functionalized pyrazolidines. Org. Lett. 2000, 2, 4265–4267.
26. Vedso, P.; Begtrup, M. Synthesis of 5-substituted 1-hydroxypyrazoles through directed lithiation
of 1-(benzyloxy) pyrazole. J. Org. Chem. 1995, 60, 4995–4998.
27. Gupta, R.; Gupta, N.; Jain, A. Improved synthesis of chalcones and pyrazolines under ultrasonic
irradiation. Ind. J. Chem. 2010, 49B, 351–355.
Molecules 2012, 17 4971

28. Nakamichi, N.; Kawashita, Y.; Hayashi, M. Oxidative aromatization of 1,3,5-trisubstituted

pyrazolines and hantzsch 1,4-dihydropyridines by Pd/C in acetic acid. Org. Lett. 2002, 4,
3955–3957.
29. Wang, S.; Shi, B.; Li, Y.; Wang, Q.; Huang, R. A convenient synthesis of novel 4-(1,2, 4-triazol-
1-yl)-2-pyrazolines and their derivatives. Synth. Commun. 2003, 33, 1449–1457.
30. Chen, Y.; Lam, Y.; Lai, Y.H. Solid-phase synthesis of pyrazolines and isoxazolines with sodium
benzene sulfinate as a traceless linker. Org. Lett. 2003, 5, 1067–1069.
31. Stephen, A.F.; Philip, D.P. Reexamination of the Claisen-Schmidt condensation of phenylacetone
with aromatic aldehydes. J. Org. Chem. 1973, 38, 1747–1749.
32. Hamed, E.A.; Sharaf, S.M.; Abdel-Baky, S.A.; Ibrahim, M.F.; Youssef, A.A. Stereochemistry and
kinetics of addition of amines to acetylenic ketones. J. Phys. Org. Chem. 1990, 3, 627–634.
33. Ansari, F.L.; Nazir, S.; Noureen, H.; Miraza, B. Combinatorial synthesis and antibacterial
evaluation of an indexed chalcone library. Chem. Biodivers. 2005, 2, 1656–1664.

Sample Availability: Samples of all the compounds are available from the authors.

© 2012 by the authors; licensee MDPI, Basel, Switzerland. This article is an open access article
distributed under the terms and conditions of the Creative Commons Attribution license
(http://creativecommons.org/licenses/by/3.0/).